Global Antivirals Market Analysis 2024 – Estimated Market Size And Key Drivers

The Antivirals Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2011-2022) and extends its insights into a ten-year forecast period (2024-2033).

Learn More On The Antivirals Market:
https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

According to The Business Research Company’s Antivirals Global Market Report 2024, The antivirals market size has grown strongly in recent years. It will grow from $97.72 billion in 2023 to $105.73 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%.  The  growth in the historic period can be attributed to viral disease prevalence, public health concerns, patent expirations, government initiatives.

The antivirals market size is expected to see strong growth in the next few years. It will grow to $143.83 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%.  The growth in the forecast period can be attributed to emerging viral threats, global health initiatives. Major trends in the forecast period include technological advances, telemedicine and digital health, personalized medicine.

The increasing incidence of influenza is anticipated to propel the growth of the antiviral market going forward. Influenza, also called flu, is a highly contagious viral respiratory infection caused by influenza viruses that affect the nose, throat, and lungs. Antivirals are used for the treatment of influenza and are designed to inhibit the replication and spread of influenza viruses within the body. For instance, in October 2022, according to the Centers for Disease Control and Prevention, a US-based health agency, during 2021-2022 season, there were 9 million flu illnesses, 4 million flu-related medical visits, 100,000 flu-related hospitalizations, and 5,000 flu deaths. Therefore, the increasing incidence of influenza is driving the growth of the antiviral market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=2437&type=smp

The antivirals market covered in this report is segmented –
1) By Type: Branded; Generic
2) By Drug Class: DNA Polymerase Inhibitors; Reverse Transcriptase Inhibitors; Protease Inhibitors; Neuraminidase Inhibitors; Other Drug classes
3) By Application: HIV; Hepatitis; Herpes; Influenza; Other Applications

The antivirals market report table of contents includes:
1. Executive Summary

2. Antivirals Market Characteristics
3. Antivirals Market Trends And Strategies
4. Antivirals Market – Macro Economic Scenario
5. Global Antivirals Market Size and Growth
   .
   31. Global Antivirals Market Competitive Benchmarking
6. Global Antivirals Market Competitive Dashboard
7. Key Mergers And Acquisitions In The Antivirals Market
8. Antivirals Market Future Outlook and Potential Analysis
9. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model